Search research articles
Contact Us
Filters
Showing results (81-90 of 266) with videos related to
Page
of 27
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 24, 2022
Development of in vitro and in vivo tools to evaluate the antiangiogenic potential of melatonin to neutralize the angiogenic effects of VEGF and breast cancer cells: CAM assay and 3D endothelial cell spheroids
Aurora Laborda-Illanes, Lidia Sánchez-Alcoholado, Daniel Castellano-Castillo, et al.
Journal for Immunotherapy of Cancer
|
January 10, 2023
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors
Aristotelis Bamias, Axel Merseburger, Yohann Loriot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2014
Phase II results of Dovitinib (TKI258) in patients with metastatic renal cell cancer
Bernard Escudier, Viktor Grünwald, Alain Ravaud, et al.
BJU International
|
July 13, 2020
Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first-line metastatic renal carcinoma (SUNRISES study)
Alejo Rodriguez-Vida, Aristotelis Bamias, Emilio Esteban, et al.
Biomolecules
|
May 15, 2020
Relationship of Zonulin with Serum PCSK9 Levels after a High Fat Load in a Population of Obese Subjects
María Molina-Vega, Daniel Castellano-Castillo, Lidia Sánchez-Alcoholado, et al.
The New England Journal of Medicine
|
February 12, 2021
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
Thomas Powles, Jonathan E Rosenberg, Guru P Sonpavde, et al.
International Journal of Obesity (2005)
|
May 3, 2018
Identification of an episignature of human colorectal cancer associated with obesity by genome-wide DNA methylation analysis
Ana B Crujeiras, Sonsoles Morcillo, Angel Diaz-Lagares, et al.
European Journal of Clinical Pharmacology
|
September 22, 2015
Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma
Meta H M Diekstra, Xiaoyan Liu, Jesse J Swen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2022
Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study
Federico Longo-Muñoz, Daniel Castellano, Jerome Alexandre, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2017
Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer
Christophe Massard, Kim Nguyen Chi, Daniel Castellano, et al.
Page
of 27
Search research articles
Search
Showing results (81-90 of 266) with videos related to
Sort By:
Page
of 27
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 24, 2022
Development of in vitro and in vivo tools to evaluate the antiangiogenic potential of melatonin to neutralize the angiogenic effects of VEGF and breast cancer cells: CAM assay and 3D endothelial cell spheroids
Aurora Laborda-Illanes, Lidia Sánchez-Alcoholado, Daniel Castellano-Castillo, et al.
Journal for Immunotherapy of Cancer
|
January 10, 2023
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors
Aristotelis Bamias, Axel Merseburger, Yohann Loriot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2014
Phase II results of Dovitinib (TKI258) in patients with metastatic renal cell cancer
Bernard Escudier, Viktor Grünwald, Alain Ravaud, et al.
BJU International
|
July 13, 2020
Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first-line metastatic renal carcinoma (SUNRISES study)
Alejo Rodriguez-Vida, Aristotelis Bamias, Emilio Esteban, et al.
Biomolecules
|
May 15, 2020
Relationship of Zonulin with Serum PCSK9 Levels after a High Fat Load in a Population of Obese Subjects
María Molina-Vega, Daniel Castellano-Castillo, Lidia Sánchez-Alcoholado, et al.
The New England Journal of Medicine
|
February 12, 2021
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
Thomas Powles, Jonathan E Rosenberg, Guru P Sonpavde, et al.
International Journal of Obesity (2005)
|
May 3, 2018
Identification of an episignature of human colorectal cancer associated with obesity by genome-wide DNA methylation analysis
Ana B Crujeiras, Sonsoles Morcillo, Angel Diaz-Lagares, et al.
European Journal of Clinical Pharmacology
|
September 22, 2015
Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma
Meta H M Diekstra, Xiaoyan Liu, Jesse J Swen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2022
Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study
Federico Longo-Muñoz, Daniel Castellano, Jerome Alexandre, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2017
Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer
Christophe Massard, Kim Nguyen Chi, Daniel Castellano, et al.
Page
of 27